focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on debt refinancing and CSS

19 Dec 2023 11:15

RNS Number : 3158X
Barkby Group PLC
19 December 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

Barkby Group PLC

 

("Barkby", or the "Company") 

 

 

Update on debt refinancing and Cambridge Sleep Sciences

 

Barkby, (AIM: BARK) the roadside real estate business, provides an update on its intention to refinance its existing debt facilities further to the announcement on 4 December 2023.

 

The Company has engaged in several constructive discussions with prospective investors in relation to its proposed private debt offering. It is currently envisaged that the Company's current facilities will be refinanced via a private debt instrument, issued at a coupon of 14% for a period of 24 months. This instrument would be secured against the Company's wholly owned Real Estate assets and its 75% shareholding in Cambridge Sleep Sciences, ("CSS"). The terms of the debt may also bestow the right upon holders to participate in an exit option of the Company's CSS shareholding under preferential terms, or to benefit from a profit share agreement. Final terms remain subject to negotiation.

 

Investors and existing Barkby shareholders who wish to participate in the private debt offering should contact ir@barkbygroup.com.

 

Cambridge Sleep Sciences

CSS has made encouraging progress on several new multi-year licensing, streaming and royalty contracts with blue chip multi-national customers across TVs, Smart Watches, Pillows, Mattresses and Hotels. Since the last update on 29 September 2023, CSS's pipeline has continued to strengthen and it is in the final stages of negotiation on a number of new agreements. The Company will continue to update shareholders as appropriate.

 

The Board continues to evaluate the best corporate setting to maximise shareholder value from its investment in CSS and has begun exploring opportunities for a potential trade sale and de-merger. There can be no certainty that any de-merger or sale of CSS will ultimately be made or the value of any such possible deal.

 

 

- Ends -

 

 

Enquiries:

 

Barkby Group PLC

Charles Dickson, Executive Chairman

c/o Montfort

 

Montfort

Olly Scott

Georgia Colkin

 

 

+44 (0)78 1234 5205

+44 (0)75 4284 6844

Cavendish Capital Markets Limited (Nomad and Broker)

Carl Holmes / Simon Hicks / Fergus Sullivan (Corporate Finance)

Tim Redfern (ECM)

 

+44 (0)20 7220 0500

Stifel Nicolaus Europe Limited (Financial Adviser and Joint Corporate Broker)

Mark Young

Jonathan Wilkes-Green

Catriona Neville

+44 (0)20 7710 7600

 

 

About Barkby

Barkby is a roadside real estate business focused on building and scaling a high-quality portfolio of modern assets.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTLBMTMTABBPJ
12
Date   Source Headline
27th Oct 20219:05 amRNSSecond Price Monitoring Extn
27th Oct 20219:00 amRNSPrice Monitoring Extension
27th Oct 20217:00 amRNSTrading Statement and Property Acquisition
10th Aug 20217:00 amRNSTrading Statement
16th Jun 20217:00 amRNSNew lease for The Ebrington Arms
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
7th May 20211:48 pmRNSResult of AGM and change of name
30th Apr 20217:00 amRNSInterim Results
15th Apr 20217:00 amRNSCambridge Sleep Sciences signs new partners
9th Apr 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Apr 20217:00 amRNSVerso Biosense signs collaboration agreement
31st Mar 20216:29 pmRNSFinal Results
25th Mar 20217:00 amRNSVerso Biosense signs agreement with hospital
11th Mar 20217:00 amRNSCambridge Sleep Sciences partnership announcement
3rd Mar 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSExchange of Contracts at Malden, Essex
24th Dec 20207:00 amRNSExtension of Warrants
21st Dec 20207:00 amRNSExercise of Warrants and Total Voting Rights
6th Nov 20207:03 amRNSExtension of Reporting Deadline
30th Oct 20207:00 amRNSWorkshop Coffee becomes UK Distributor for MiiR
23rd Oct 20207:00 amRNSCambridge Sleep Sciences Ltd launches 'SleepHub™'
30th Sep 20207:00 amRNSCompany Update and Issue of Equity
17th Sep 20207:00 amRNSNew lease for The Harcourt Arms
10th Aug 20207:00 amRNSPractical Completion of Hastings
3rd Aug 20207:00 amRNSInvestment in VivoPlex Group
22nd Jul 20207:00 amRNSUpdate and CBILS loan
21st Apr 20207:00 amRNSAgreement with Cambridge Sound Technologies
20th Apr 20207:32 amRNSVivoPlex prepares for clinical feasibility study
24th Mar 20202:57 pmRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSConfirmation of Director Appointment
23rd Mar 20207:00 amRNSInterim Results
3rd Mar 20207:00 amRNSProposed acquisition
6th Feb 20207:00 amRNSAppointment of Senior Manager
3rd Feb 20207:00 amRNSAppointment of Chief Financial Officer
17th Jan 20207:00 amRNSExchange of Contracts at Huntingdon
7th Jan 20207:00 amRNSCompletion of Acquisition
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.